相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
David M. Peereboom et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
Jeffrey J. Raizer et al.
NEURO-ONCOLOGY (2010)
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
Sagar Agarwal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines
Dorine A. Bax et al.
CLINICAL CANCER RESEARCH (2009)
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Young age may predict a better outcome for children with diffuse pontine glioma
Alberto Broniscer et al.
CANCER (2008)
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience
Maura Massimino et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Subpopulations of malignant gliomas in pediatric patients:: analysis of the HIT-GBM database
Johannes E. A. Wolff et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study
Michael D. Prados et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A children's oncology group phase II study
David N. Korones et al.
PEDIATRIC BLOOD & CANCER (2008)
Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin
Asim Mahmood et al.
JOURNAL OF NEUROSURGERY (2007)
Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors
Demitre Serletis et al.
JOURNAL OF NEUROSURGERY (2007)
Gefitinib concentrations in human glioblastoma tissue
Silvia Hofer et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report
Ian F. Pollack et al.
NEURO-ONCOLOGY (2007)
Treatment options in childhood pontine gliomas
Sabine Wagner et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with 17-AAG on glioma cell growth
DR Premkumar et al.
MOLECULAR CARCINOGENESIS (2006)
Intraturnoral hemorrhage among children with newly diagnosed, diffuse brainstern glioma
A Broniscer et al.
CANCER (2006)
Diffuse brainstem glioma in children: critical review of clinical trials
D Hargrove et al.
LANCET ONCOLOGY (2006)
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas - Results of a French Society of Paediatric Oncology Phase II study
V Bernier-Chastagner et al.
CANCER (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: Tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
AB Lassman et al.
CLINICAL CANCER RESEARCH (2005)
Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII
MW Pedersen et al.
BRITISH JOURNAL OF CANCER (2005)
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer
T Takano et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study
NC Daw et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas
M Taron et al.
CLINICAL CANCER RESEARCH (2005)
Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests
SJ Lee et al.
PHARMACOGENOMICS (2005)
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
SW Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Determination of gefitinib in plasma by liquid chromatography with a C-12 column and electrospray tandem mass spectrometry detection
F Bai et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine
CP Zamber et al.
PHARMACOGENETICS (2003)
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients
HX Zheng et al.
HUMAN IMMUNOLOGY (2002)
Preradiation chemotherapy in primary high-risk brainstem tumors: Phase II study CCG-9941 of the children's cancer group
MT Jennings et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
